@FiercePharma: Korean pharma stocks are riding an updraft of M&A speculation. Keunwha, Hondok way up ... anyone shopping? More | Follow @FiercePharma
> The Brad PItt vehicle World War Z moved into Pfizer's ($PFE) shrinking R&D facility in Sandwich, England, for some post-apocalyptic film shooting. Report
> Generic competition for its seizure drug Keppra held back sales growth at UCB, but the anti-inflammatory drug Cimzia helped make up the gap. Report
> Many drugmakers shuttered plants and other facilities on the East Coast as Hurricane Sandy barreled through. Report
> Dr. Reddy's Laboratories posted better-than-expected profits as new generics drove a 47% increase in North American sales. Report
> Watson Pharmaceuticals ($WPI), cleaning house as it merges with Swiss-based Actavis, said it has sold its Rugby over-the-counter business to Harvard Drug Group for $117 million. Report
> Shanghai Fosun Pharma shares made an inauspicious debut on the Hong Kong exchange, with a 12% decline in price on the heels of its $512 million offering. Report
> Par Pharmaceutical bought the rights to sell generic Seroquel XR from Handa Pharmaceuticals, which believes it's entitled to 180-day exclusivity as the first to file for FDA approval. Report
> Korean drugmakers Keuwha Pharmaceutical and Hondok Pharmaceutical rose on an updraft of M&A speculation, as investors look for buyout targets in the consolidating sector. Report
@FierceMedDev: Ariste Medical raised $1.275M in seed money to advance development of a drug-coated vascular graft. More | Follow @FierceMedDev
@MarkHFierce: CryoLife celebrates 13% revenue jump in Q3. More | Follow @MarkHFierce
@DamianFierce: Orthofix pays $32M to settle allegations it gave kickbacks--including parties with strippers & prostitutes--to docs. More | Follow @DamianFierce
> Report: Global neuromodulation device market ripe for double-digit growth. Item
> Medtronic looks to unseat Edwards with heart valve. Report
Biotech News
@FierceBiotech: Alzheimers investigators see fresh sign of solanezumab success in $LLY study. More | Follow @FierceBiotech
@JohnCFierce: Biotech companies out there. You have any bad news to report? Do it now. Take advantage of the perfect storm to confess your sins quietly. | Follow @JohnCFierce
@RyanMFierce: Focusing on hoped-for launch of tivozanib, $AVEO is axing 45 jobs or 17% of workers, eliminating 30 openings. More | Follow @RyanMFierce
> Cigarette maker Philip Morris rolls vaccine interests into China. Story
> Financial woes reduce AstraZeneca's industry profile. Item
> Theratechnologies once again tries to slash its way to breakeven point. Article
Pharma Manufacturing News
> Boehringer again doubling capacity at inhaler plant. Report
> Patheon will pick up four plants with Banner buyout. News
> Congressional report calls for FDA to regulate large compounders. Article
> Drugmakers close plants ahead in face of Hurricane Sandy. Item
Biotech Research News
> Wisconsin company to provide stem cells for NIH research. Story
> Roche drug, microRNA treatment conquered head and neck cancer cells. News
> Baker's yeast yields possible Lou Gehrig's disease drug target. Article
> Duke team builds viable cartilage from induced pluripotent stem cells. Report
And Finally... Perfectionist? Don't blame your parents, blame their genes, a study finds. Report